Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Pharmacist Stigma a Barrier to Rural Buprenorphine Access

Publish date:: August 27, 2019

Key clinical point: Pharmacies can be a barrier to medication for opioid use disorder.

Major finding: Of 14 pharmacies, 4 refused to dispense buprenorphine, while 5 rationed prescriptions.

Study details: The findings are based on a qualitative study involving 14 pharmacists in two rural Kentucky health districts.

Disclosures: The research was funded by the National Institutes of Health through CARE2HOPE, Rural Health Project, and the Emory Center for AIDS Research. The authors reported no disclosures.

Citation:

REPORTING FROM CPDD 2019

This Week's Must Reads

MDD: Modest improvements in female sexual functioning with adjunctive brexpiprazole,

Transcranial direct current stimulation not clinically relevant in MDD,

Interleukin-1 β and TNF-α hamper antidepressant response in MDD,

Impact of pimavanserin on anxious depression in patients with MDD,

Prior MDD moderates the association between endothelin-1 and post-ACS depressive symptoms,

Must Reads in Addiction Medicine

E-cigarette use tied to increased COPD, asthma risk,

National lung cancer screening guidelines may miss younger African American individuals at high risk,

Alcohol problems linked to legal performance-enhancement products,

Report describes intoxication with new psychoactive substance,

Adolescent alcohol, opioid misuse linked to risky behaviors,